Impact of symptomatic interval on prognosis of patients with stage III testicular cancer.
暂无分享,去创建一个
N. Geller | H. Scher | W. Whitmore | C. Cirrincione | G. Bosl | R. Golbey
[1] S. Snyder,et al. Neurotransmitters and CNS disease. Schizophrenia. , 1982, The Lancet.
[2] P. Lange,et al. IMPACT OF DELAY IN DIAGNOSIS ON CLINICAL STAGE OF TESTICULAR CANCER , 1981, The Lancet.
[3] L. Einhorn. Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. , 1981, Cancer research.
[4] W. Whitmore,et al. VAB‐3 combination chemotherapy of metastatic testicular cancer , 1981, Cancer.
[5] W. Whitmore,et al. VAB–4 combination chemotherapy in the treatment of metastatic testis tumors , 1981, Cancer.
[6] T. Waldmann,et al. Testicular germ-cell neoplasms: recent advances in diagnosis and therapy. , 1979, Annals of internal medicine.
[7] R. Wittes,et al. Germ cell tumors (II). VAB II in metastatic testicular cancer , 1978, Cancer.
[8] R. Wittes,et al. Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin , 1976, Cancer.
[9] J. Patton,et al. Diagnosis and treatment of tumors of the testis. , 1959, Journal of the American Medical Association.